Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q59739583
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000121.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q59739583
|
035
|
|
|
‡a
(OCoLC)Q59739583
|
100
|
0 |
|
‡a
Arthur D Smith
‡9
es
‡9
ast
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
আর্থার ডি স্মিথ
‡9
bn
|
400
|
0 |
|
‡a
Arthur D Smith
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Arthur D Smith
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?
|
670
|
|
|
‡a
Author's A Case for Nephron Sparing Surgery in the Management of Upper Tract Urothelial Carcinoma
|
670
|
|
|
‡a
Author's A personal perspective on the origins of endourology and the endourological society.
|
670
|
|
|
‡a
Author's A Randomized Controlled Comparison of Nephrostomy Drainage vs Ureteral Stent Following Percutaneous Nephrolithotomy Using the Wisconsin StoneQOL.
|
670
|
|
|
‡a
Author's Advanced therapy for prostatitis: minimally invasive and invasive therapies
|
670
|
|
|
‡a
Author's Advances in percutaneous stone surgery.
|
670
|
|
|
‡a
Author's Anatomical variation between the prone, supine, and supine oblique positions on computed tomography: implications for percutaneous nephrolithotomy access.
|
670
|
|
|
‡a
Author's "Angular percutaneous renal access". Multiple tracts through a single incision for staghorn calculous treatment in a single session
|
670
|
|
|
‡a
Author's Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition
|
670
|
|
|
‡a
Author's Association of serum biochemical metabolic panel with stone composition
|
670
|
|
|
‡a
Author's Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role?
|
670
|
|
|
‡a
Author's Bladder Necrosis Associated with Placenta Accreta, Embolization, and Repair of Cystotomies
|
670
|
|
|
‡a
Author's Calyceal diverticula: a comprehensive review.
|
670
|
|
|
‡a
Author's Can Activities of Daily Living Predict Complications following Percutaneous Nephrolithotomy?
|
670
|
|
|
‡a
Author's Comparative study of degree of renal trauma between Amplatz sequential fascial dilation and balloon dilation during percutaneous renal surgery in an animal model
|
670
|
|
|
‡a
Author's Comparison of laparoscopic saline infused to dry radio frequency ablation of renal tissue: evolution of histological infarct in the porcine model.
|
670
|
|
|
‡a
Author's Comparison of robotic versus laparoscopic skills: is there a difference in the learning curve?
|
670
|
|
|
‡a
Author's Comparison of the mechanical, flow, and optical properties of contemporary flexible ureteroscopes.
|
670
|
|
|
‡a
Author's Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers
|
670
|
|
|
‡a
Author's Conservative Management of Combined Pleural and Splenic Injury During Percutaneous Nephrostolithotomy
|
670
|
|
|
‡a
Author's Contemporary assessment of renal stone complexity using cross-sectional imaging
|
670
|
|
|
‡a
Author's Continuing aspirin therapy during percutaneous nephrolithotomy: unsafe or under-utilized?
|
670
|
|
|
‡a
Author's Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma
|
670
|
|
|
‡a
Author's Crossing vessels are not important in the etiology of ureteropelvic junction obstruction
|
670
|
|
|
‡a
Author's Cryotherapy of the nephrostomy tract: a novel technique to decrease the risk of hemorrhage after tubeless percutaneous renal surgery.
|
670
|
|
|
‡a
Author's Diagnosis and Management of a Prolapsing Intravesical Ureterocele in a Man.
|
670
|
|
|
‡a
Author's Diagnostic Utility and Clinical Value of Postpercutaneous Nephrolithotomy Nephrostogram
|
670
|
|
|
‡a
Author's Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus
|
670
|
|
|
‡a
Author's Differences in 24-hour urine composition between apatite and brushite stone formers
|
670
|
|
|
‡a
Author's Difficulties with access in percutaneous renal surgery
|
670
|
|
|
‡a
Author's Digital nephroscopy: the next step
|
670
|
|
|
‡a
Author's Digital ureteroscopy: the next step
|
670
|
|
|
‡a
Author's Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis?
|
670
|
|
|
‡a
Author's Does Peak Inspiratory Pressure Increase in the Prone Position? An Analysis Related to Body Mass Index
|
670
|
|
|
‡a
Author's Effects of pneumoperitoneal gases and pressures on transitional cell carcinoma adhesion, growth, apoptosis and necrosis: an in vitro study.
|
670
|
|
|
‡a
Author's Efficacy and morbidity of therapeutic renal embolization in the spectrum of urologic disease
|
670
|
|
|
‡a
Author's Encrusted urinary stents: evaluation and endourologic management
|
670
|
|
|
‡a
Author's Endoscopic management of renal lymphangioma: a case report
|
670
|
|
|
‡a
Author's Endourologic treatment of upper urinary tract transitional cell carcinoma
|
670
|
|
|
‡a
Author's Evaluation and comparison of urolithiasis scoring systems used in percutaneous kidney stone surgery
|
670
|
|
|
‡a
Author's First Prize (tie): Hemorrhage following percutaneous renal surgery: characterization of angiographic findings
|
670
|
|
|
‡a
Author's First prize: ureteral segmental replacement revisited
|
670
|
|
|
‡a
Author's Hand-assisted laparoscopic renal surgery: current trends and applications
|
670
|
|
|
‡a
Author's Hand pain during hand assisted laparoscopic nephrectomy--an ischemic event?
|
670
|
|
|
‡a
Author's High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis
|
670
|
|
|
‡a
Author's Immune response to laparoscopic bowel injury.
|
670
|
|
|
‡a
Author's Indications for adult circumcision: a contemporary analysis
|
670
|
|
|
‡a
Author's Laparoscopic heminephrectomy for benign disease of the horseshoe kidney
|
670
|
|
|
‡a
Author's Laparoscopic port site metastases: incidence, risk factors, and potential preventive measures
|
670
|
|
|
‡a
Author's Laparoscopic pyeloplasty versus antegrade endopyelotomy: comparison in 100 patients and a new algorithm for the minimally invasive treatment of ureteropelvic junction obstruction
|
670
|
|
|
‡a
Author's Laparoscopic versus open radical nephrectomy for xanthogranulomatous pyelonephritis: Contemporary outcomes analysis
|
670
|
|
|
‡a
Author's Lasers in percutaneous renal procedures
|
670
|
|
|
‡a
Author's Live surgical demonstrations: an old, but increasingly controversial practice
|
670
|
|
|
‡a
Author's Malignant ureteral obstruction: the case for plastic ureteral stents
|
670
|
|
|
‡a
Author's Management of hemorrhagic complications associated with percutaneous nephrolithotomy
|
670
|
|
|
‡a
Author's Management of urolithiasis in patients after urinary diversions
|
670
|
|
|
‡a
Author's Medical malpractice in endourology: analysis of closed cases from the State of New York
|
670
|
|
|
‡a
Author's Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer
|
670
|
|
|
‡a
Author's Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection
|
670
|
|
|
‡a
Author's Multicenter External Validation and Comparison of Stone Scoring Systems in Predicting Outcomes After Percutaneous Nephrolithotomy
|
670
|
|
|
‡a
Author's Nephrolithometric Scoring Systems to Predict Outcomes of Percutaneous Nephrolithotomy
|
670
|
|
|
‡a
Author's Nephrostolithotomy: percutaneous techniques for urinary calculus removal. 1982.
|
670
|
|
|
‡a
Author's Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction
|
670
|
|
|
‡a
Author's Obstructive uropathy from locally advanced and metastatic prostate cancer: an old problem with new therapies
|
670
|
|
|
‡a
Author's Optimal Lesion Assessment Following Acute Radio Frequency Ablation of Porcine Kidney: Cellular Viability or Histopathology?
|
670
|
|
|
‡a
Author's Pelvic kidney: associated diseases and treatment
|
670
|
|
|
‡a
Author's Percutaneous cholecystolithotomy: a case for fulguration of the gallbladder wall.
|
670
|
|
|
‡a
Author's Percutaneous management of staghorn calculi in horseshoe kidneys: a multi-institutional experience
|
670
|
|
|
‡a
Author's Percutaneous Nephrolithotomy
|
670
|
|
|
‡a
Author's Percutaneous nephrolithotomy during uninterrupted aspirin therapy in high-cardiovascular risk patients: preliminary report.
|
670
|
|
|
‡a
Author's Percutaneous nephrolithotomy in octogenarians and beyond: How old is too old?
|
670
|
|
|
‡a
Author's Percutaneous nephrolithotomy in super obese patients (body mass index ≥ 50 kg/m²): overcoming the challenges
|
670
|
|
|
‡a
Author's Percutaneous Nephrolithotomy (PCNL) in Obese Patients: Overcoming the Difficulties
|
670
|
|
|
‡a
Author's Percutaneous nephrostolithotomy: an assessment of costs for prone and Galdakao-modified supine Valdivia positioning
|
670
|
|
|
‡a
Author's Percutaneous Renal Access
|
670
|
|
|
‡a
Author's Percutaneous renal access: tips and tricks
|
670
|
|
|
‡a
Author's Performing in the surgical amphitheater of today: perception of urologists conducting live case demonstrations
|
670
|
|
|
‡a
Author's Peritoneal and systemic inflammatory mediators of laparoscopic bowel injury in a rabbit model.
|
670
|
|
|
‡a
Author's Pneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor- Alpha secretion: source of transitional-cell carcinoma port-site metastasis, with prophylactic irrigation strategies to decrease laparoscopic oncologic risks
|
670
|
|
|
‡a
Author's Practice trends in contemporary management of adult ureteropelvic junction obstruction
|
670
|
|
|
‡a
Author's Predictive factors for intraoperative balloon dilation in semirigid ureteroscopic lithotripsy
|
670
|
|
|
‡a
Author's Prospective comparison of outcomes of percutaneous nephrolithotomy in elderly patients versus younger patients
|
670
|
|
|
‡a
Author's RE: "Mn-porphyrins as novel molecular MRI contrast agents" by Mouraviev et al.
|
670
|
|
|
‡a
Author's Real-time quantitation of renal ischemia using targeted microbubbles: in-vivo measurement of P-selectin expression
|
670
|
|
|
‡a
Author's Reconstruction of rabbit urethra with surgisis small intestinal submucosa
|
670
|
|
|
‡a
Author's Renal drainage after percutaneous nephrolithotomy
|
670
|
|
|
‡a
Author's Renal functional outcomes are not adversely affected by selective angioembolization following percutaneous nephrolithotomy.
|
670
|
|
|
‡a
Author's Renal pelvic stones: choosing shock wave lithotripsy or percutaneous nephrolithotomy
|
670
|
|
|
‡a
Author's Reply: To PMID 23540858.
|
670
|
|
|
‡a
Author's Residual Air Persists in the Renal Collecting System following Percutaneous Nephrolithotomy
|
670
|
|
|
‡a
Author's Rigid-only versus combined rigid and flexible percutaneous nephrolithotomy: a systematic review
|
670
|
|
|
‡a
Author's Role of acellular collagen matrix surgisis in the endoscopic management of ureteropelvic junction obstruction.
|
670
|
|
|
‡a
Author's S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi.
|
670
|
|
|
‡a
Author's Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents
|
670
|
|
|
‡a
Author's Stones in special situations
|
670
|
|
|
‡a
Author's Symptoms after removal of ureteral stents
|
670
|
|
|
‡a
Author's Tail stent versus re-entry tube: a randomized comparison after percutaneous stone extraction.
|
670
|
|
|
‡a
Author's Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy
|
670
|
|
|
‡a
Author's The debate over percutaneous nephrolithotomy positioning: a comprehensive review
|
670
|
|
|
‡a
Author's The endourological management of complications associated with horseshoe kidney
|
670
|
|
|
‡a
Author's The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience
|
670
|
|
|
‡a
Author's The genetic framework for development of nephrolithiasis.
|
670
|
|
|
‡a
Author's The surgical spectacle: a survey of urologists viewing live case demonstrations.
|
670
|
|
|
‡a
Author's Trends in ureteropelvic junction obstruction management among urologists in the United States
|
670
|
|
|
‡a
Author's Tubular cell-Escherichia coli interaction products modulate migration of monocytes through generation of transforming growth factor-beta and macrophage-monocyte chemoattractant protein-1.
|
670
|
|
|
‡a
Author's Ureteropelvic junction obstruction repair: when, how, what?
|
670
|
|
|
‡a
Author's Urinary tract infections and post-operative fever in percutaneous nephrolithotomy
|
670
|
|
|
‡a
Author's Using 24-hour urinalysis to predict stone type
|
670
|
|
|
‡a
Author's Videourology: an historical perspective and a view to the future. Interview by Ralph V. Clayman
|
670
|
|
|
‡a
Author's Which Is Better? "Live" Surgical Broadcasts vs "As-Live" Surgical Broadcasts
|
919
|
|
|
‡a
remnporphyrinsasnovelmolecularmricontrastagentsbymouravievetal
‡A
RE: "Mn-porphyrins as novel molecular MRI contrast agents" by Mouraviev et al.
‡9
1
|
919
|
|
|
‡a
prospectivecomparisonofoutcomesofpercutaneousnephrolithotomyinelderlypatientsversusyoungerpatients
‡A
Prospective comparison of outcomes of percutaneous nephrolithotomy in elderly patients versus younger patients
‡9
1
|
919
|
|
|
‡a
predictivefactorsforintraoperativeballoondilationinsemirigidureteroscopiclithotripsy
‡A
Predictive factors for intraoperative balloon dilation in semirigid ureteroscopic lithotripsy
‡9
1
|
919
|
|
|
‡a
practicetrendsincontemporarymanagementofadultureteropelvicjunctionobstruction
‡A
Practice trends in contemporary management of adult ureteropelvic junction obstruction
‡9
1
|
919
|
|
|
‡a
pneumoperitoneumwithcarbondioxideinhibitsmacrophagetumornecrosisfactor Alpha secretionsourceoftransitionalcellcarcinomaportsitemetastasiswithprophylacticirrigationstrategiestodecreaselaparoscopiconcologicrisks
‡A
Pneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor- Alpha secretion: source of transitional-cell carcinoma port-site metastasis, with prophylactic irrigation strategies to decrease laparoscopic oncologic risks
‡9
1
|
919
|
|
|
‡a
peritonealandsystemicinflammatorymediatorsoflaparoscopicbowelinjuryinarabbitmodel
‡A
Peritoneal and systemic inflammatory mediators of laparoscopic bowel injury in a rabbit model.
‡9
1
|
919
|
|
|
‡a
performinginthesurgicalamphitheateroftodayperceptionofurologistsconductinglivecasedemonstrations
‡A
Performing in the surgical amphitheater of today: perception of urologists conducting live case demonstrations
‡9
1
|
919
|
|
|
‡a
percutaneousrenalaccesstipsandtricks
‡A
Percutaneous renal access: tips and tricks
‡9
1
|
919
|
|
|
‡a
percutaneousrenalaccess
‡A
Percutaneous Renal Access
‡9
1
|
919
|
|
|
‡a
percutaneousnephrostolithotomyanassessmentofcostsforproneandgaldakaomodifiedsupinevaldiviapositioning
‡A
Percutaneous nephrostolithotomy: an assessment of costs for prone and Galdakao-modified supine Valdivia positioning
‡9
1
|
919
|
|
|
‡a
percutaneousnephrolithotomypcnlinobesepatientsovercomingthedifficulties
‡A
Percutaneous Nephrolithotomy (PCNL) in Obese Patients: Overcoming the Difficulties
‡9
1
|
919
|
|
|
‡a
percutaneousnephrolithotomyinsuperobesepatientsbodymassindex50kgm2overcomingthechallenges
‡A
Percutaneous nephrolithotomy in super obese patients (body mass index ≥ 50 kg/m²): overcoming the challenges
‡9
1
|
919
|
|
|
‡a
percutaneousnephrolithotomyinoctogenariansandbeyondhowoldistooold
‡A
Percutaneous nephrolithotomy in octogenarians and beyond: How old is too old?
‡9
1
|
919
|
|
|
‡a
percutaneousnephrolithotomyduringuninterruptedaspirintherapyinhighcardiovascularriskpatientspreliminaryreport
‡A
Percutaneous nephrolithotomy during uninterrupted aspirin therapy in high-cardiovascular risk patients: preliminary report.
‡9
1
|
919
|
|
|
‡a
percutaneousnephrolithotomy
‡A
Percutaneous Nephrolithotomy
‡9
1
|
919
|
|
|
‡a
percutaneousmanagementofstaghorncalculiinhorseshoekidneysamultiinstitutionalexperience
‡A
Percutaneous management of staghorn calculi in horseshoe kidneys: a multi-institutional experience
‡9
1
|
919
|
|
|
‡a
percutaneouscholecystolithotomyacaseforfulgurationofthegallbladderwall
‡A
Percutaneous cholecystolithotomy: a case for fulguration of the gallbladder wall.
‡9
1
|
919
|
|
|
‡a
pelvickidneyassociateddiseasesandtreatment
‡A
Pelvic kidney: associated diseases and treatment
‡9
1
|
919
|
|
|
‡a
optimallesionassessmentfollowingacuteradiofrequencyablationofporcinekidneycellularviabilityorhistopathology
‡A
Optimal Lesion Assessment Following Acute Radio Frequency Ablation of Porcine Kidney: Cellular Viability or Histopathology?
‡9
1
|
919
|
|
|
‡a
obstructiveuropathyfromlocallyadvancedandmetastaticprostatecanceranoldproblemwithnewtherapies
‡A
Obstructive uropathy from locally advanced and metastatic prostate cancer: an old problem with new therapies
‡9
1
|
919
|
|
|
‡a
novelduallumenureteralstentsprovidebetterureteralflowthansingleureteralstentinexvivoporcinekidneymodelofextrinsicureteralobstruction
‡A
Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction
‡9
1
|
919
|
|
|
‡a
nephrostolithotomypercutaneoustechniquesforurinarycalculusremoval
‡A
Nephrostolithotomy: percutaneous techniques for urinary calculus removal. 1982.
‡9
1
|
919
|
|
|
‡a
nephrolithometricscoringsystemstopredictoutcomesofpercutaneousnephrolithotomy
‡A
Nephrolithometric Scoring Systems to Predict Outcomes of Percutaneous Nephrolithotomy
‡9
1
|
919
|
|
|
‡a
multicenterexternalvalidationandcomparisonofstonescoringsystemsinpredictingoutcomesafterpercutaneousnephrolithotomy
‡A
Multicenter External Validation and Comparison of Stone Scoring Systems in Predicting Outcomes After Percutaneous Nephrolithotomy
‡9
1
|
919
|
|
|
‡a
morphineinducedmacrophageapoptosismodulatesmigrationofmacrophagesuseofinvitromodelofurinarytractinfection
‡A
Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection
‡9
1
|
919
|
|
|
‡a
minimallyinvasivetherapyforuppertracturothelialcellcancer
‡A
Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer
‡9
1
|
919
|
|
|
‡a
medicalmalpracticeinendourologyanalysisofclosedcasesfromthestateofnewyork
‡A
Medical malpractice in endourology: analysis of closed cases from the State of New York
‡9
1
|
919
|
|
|
‡a
managementofurolithiasisinpatientsafterurinarydiversions
‡A
Management of urolithiasis in patients after urinary diversions
‡9
1
|
919
|
|
|
‡a
managementofhemorrhagiccomplicationsassociatedwithpercutaneousnephrolithotomy
‡A
Management of hemorrhagic complications associated with percutaneous nephrolithotomy
‡9
1
|
919
|
|
|
‡a
malignantureteralobstructionthecaseforplasticureteralstents
‡A
Malignant ureteral obstruction: the case for plastic ureteral stents
‡9
1
|
919
|
|
|
‡a
livesurgicaldemonstrationsanoldbutincreasinglycontroversialpractice
‡A
Live surgical demonstrations: an old, but increasingly controversial practice
‡9
1
|
919
|
|
|
‡a
lasersinpercutaneousrenalprocedures
‡A
Lasers in percutaneous renal procedures
‡9
1
|
919
|
|
|
‡a
laparoscopicversusopenradicalnephrectomyforxanthogranulomatouspyelonephritiscontemporaryoutcomesanalysis
‡A
Laparoscopic versus open radical nephrectomy for xanthogranulomatous pyelonephritis: Contemporary outcomes analysis
‡9
1
|
919
|
|
|
‡a
laparoscopicpyeloplastyversusantegradeendopyelotomycomparisonin100patientsandanewalgorithmfortheminimallyinvasivetreatmentofureteropelvicjunctionobstruction
‡A
Laparoscopic pyeloplasty versus antegrade endopyelotomy: comparison in 100 patients and a new algorithm for the minimally invasive treatment of ureteropelvic junction obstruction
‡9
1
|
919
|
|
|
‡a
laparoscopicportsitemetastasesincidenceriskfactorsandpotentialpreventivemeasures
‡A
Laparoscopic port site metastases: incidence, risk factors, and potential preventive measures
‡9
1
|
919
|
|
|
‡a
laparoscopicheminephrectomyforbenigndiseaseofthehorseshoekidney
‡A
Laparoscopic heminephrectomy for benign disease of the horseshoe kidney
‡9
1
|
919
|
|
|
‡a
indicationsforadultcircumcisionacontemporaryanalysis
‡A
Indications for adult circumcision: a contemporary analysis
‡9
1
|
919
|
|
|
‡a
immuneresponsetolaparoscopicbowelinjury
‡A
Immune response to laparoscopic bowel injury.
‡9
1
|
919
|
|
|
‡a
highenergytransurethralthermotherapywithcorethermapproachestransurethralprostateresectioninoutcomeefficacyametaanalysis
‡A
High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis
‡9
1
|
919
|
|
|
‡a
handpainduringhandassistedlaparoscopicnephrectomyanischemicevent
‡A
Hand pain during hand assisted laparoscopic nephrectomy--an ischemic event?
‡9
1
|
919
|
|
|
‡a
handassistedlaparoscopicrenalsurgerycurrenttrendsandapplications
‡A
Hand-assisted laparoscopic renal surgery: current trends and applications
‡9
1
|
919
|
|
|
‡a
1prizeureteralsegmentalreplacementrevisited
‡A
First prize: ureteral segmental replacement revisited
‡9
1
|
919
|
|
|
‡a
1prizetiehemorrhagefollowingpercutaneousrenalsurgerycharacterizationofangiographicfindings
‡A
First Prize (tie): Hemorrhage following percutaneous renal surgery: characterization of angiographic findings
‡9
1
|
919
|
|
|
‡a
evaluationandcomparisonofurolithiasisscoringsystemsusedinpercutaneouskidneystonesurgery
‡A
Evaluation and comparison of urolithiasis scoring systems used in percutaneous kidney stone surgery
‡9
1
|
919
|
|
|
‡a
endourologictreatmentofupperurinarytracttransitionalcellcarcinoma
‡A
Endourologic treatment of upper urinary tract transitional cell carcinoma
‡9
1
|
919
|
|
|
‡a
endoscopicmanagementofrenallymphangiomaacasereport
‡A
Endoscopic management of renal lymphangioma: a case report
‡9
1
|
919
|
|
|
‡a
encrustedurinarystentsevaluationandendourologicmanagement
‡A
Encrusted urinary stents: evaluation and endourologic management
‡9
1
|
919
|
|
|
‡a
efficacyandmorbidityoftherapeuticrenalembolizationinthespectrumofurologicdisease
‡A
Efficacy and morbidity of therapeutic renal embolization in the spectrum of urologic disease
‡9
1
|
919
|
|
|
‡a
effectsofpneumoperitonealgasesandpressuresontransitionalcellcarcinomaadhesiongrowthapoptosisandnecrosisaninvitrostudy
‡A
Effects of pneumoperitoneal gases and pressures on transitional cell carcinoma adhesion, growth, apoptosis and necrosis: an in vitro study.
‡9
1
|
919
|
|
|
‡a
doespeakinspiratorypressureincreaseinthepronepositionananalysisrelatedtobodymassindex
‡A
Does Peak Inspiratory Pressure Increase in the Prone Position? An Analysis Related to Body Mass Index
‡9
1
|
919
|
|
|
‡a
doeshypertensionimpact24hoururineparametersinpatientswithnephrolithiasis
‡A
Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis?
‡9
1
|
919
|
|
|
‡a
digitalureteroscopythenextstep
‡A
Digital ureteroscopy: the next step
‡9
1
|
919
|
|
|
‡a
digitalnephroscopythenextstep
‡A
Digital nephroscopy: the next step
‡9
1
|
919
|
|
|
‡a
difficultieswithaccessinpercutaneousrenalsurgery
‡A
Difficulties with access in percutaneous renal surgery
‡9
1
|
919
|
|
|
‡a
differencesin24hoururinecompositionbetweenapatiteandbrushitestoneformers
‡A
Differences in 24-hour urine composition between apatite and brushite stone formers
‡9
1
|
919
|
|
|
‡a
differencesin24hurinecompositionbetweennephrolithiasispatientswithandwithoutdiabetesmellitus
‡A
Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus
‡9
1
|
919
|
|
|
‡a
diagnosticutilityandclinicalvalueofpostpercutaneousnephrolithotomynephrostogram
‡A
Diagnostic Utility and Clinical Value of Postpercutaneous Nephrolithotomy Nephrostogram
‡9
1
|
919
|
|
|
‡a
diagnosisandmanagementofaprolapsingintravesicalureteroceleinaman
‡A
Diagnosis and Management of a Prolapsing Intravesical Ureterocele in a Man.
‡9
1
|
919
|
|
|
‡a
cryotherapyofthenephrostomytractanoveltechniquetodecreasetheriskofhemorrhageaftertubelesspercutaneousrenalsurgery
‡A
Cryotherapy of the nephrostomy tract: a novel technique to decrease the risk of hemorrhage after tubeless percutaneous renal surgery.
‡9
1
|
919
|
|
|
‡a
crossingvesselsarenotimportantintheetiologyofureteropelvicjunctionobstruction
‡A
Crossing vessels are not important in the etiology of ureteropelvic junction obstruction
‡9
1
|
919
|
|
|
‡a
correlationofureteroscopicappearancewithhistologicgradeofuppertracttransitionalcellcarcinoma
‡A
Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma
‡9
1
|
919
|
|
|
‡a
continuingaspirintherapyduringpercutaneousnephrolithotomyunsafeorunderutilized
‡A
Continuing aspirin therapy during percutaneous nephrolithotomy: unsafe or under-utilized?
‡9
1
|
919
|
|
|
‡a
contemporaryassessmentofrenalstonecomplexityusingcrosssectionalimaging
‡A
Contemporary assessment of renal stone complexity using cross-sectional imaging
‡9
1
|
919
|
|
|
‡a
conservativemanagementofcombinedpleuralandsplenicinjuryduringpercutaneousnephrostolithotomy
‡A
Conservative Management of Combined Pleural and Splenic Injury During Percutaneous Nephrostolithotomy
‡9
1
|
919
|
|
|
‡a
comparisonofthemetabolicprofileofmixedcalciumoxalateuricacidstoneformerstothatofpurecalciumoxalateandpureuricacidstoneformers
‡A
Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers
‡9
1
|
919
|
|
|
‡a
comparisonofthemechanicalflowandopticalpropertiesofcontemporaryflexibleureteroscopes
‡A
Comparison of the mechanical, flow, and optical properties of contemporary flexible ureteroscopes.
‡9
1
|
919
|
|
|
‡a
comparisonofroboticversuslaparoscopicskillsisthereadifferenceinthelearningcurve
‡A
Comparison of robotic versus laparoscopic skills: is there a difference in the learning curve?
‡9
1
|
919
|
|
|
‡a
comparisonoflaparoscopicsalineinfusedtodryradiofrequencyablationofrenaltissueevolutionofhistologicalinfarctintheporcinemodel
‡A
Comparison of laparoscopic saline infused to dry radio frequency ablation of renal tissue: evolution of histological infarct in the porcine model.
‡9
1
|
919
|
|
|
‡a
comparativestudyofdegreeofrenaltraumabetweenamplatzsequentialfascialdilationandballoondilationduringpercutaneousrenalsurgeryinananimalmodel
‡A
Comparative study of degree of renal trauma between Amplatz sequential fascial dilation and balloon dilation during percutaneous renal surgery in an animal model
‡9
1
|
919
|
|
|
‡a
canactivitiesofdailylivingpredictcomplicationsfollowingpercutaneousnephrolithotomy
‡A
Can Activities of Daily Living Predict Complications following Percutaneous Nephrolithotomy?
‡9
1
|
919
|
|
|
‡a
20yearexperiencewithpercutaneousresectionofuppertracttransitionalcarcinomaisthereanoncologicbenefitwithadjuvantbacilluscalmetteguerintherapy
‡A
A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?
‡9
1
|
919
|
|
|
‡a
casefornephronsparingsurgeryinthemanagementofuppertracturothelialcarcinoma
‡A
A Case for Nephron Sparing Surgery in the Management of Upper Tract Urothelial Carcinoma
‡9
1
|
919
|
|
|
‡a
personalperspectiveontheoriginsofendourologyandtheendourologicalsociety
‡A
A personal perspective on the origins of endourology and the endourological society.
‡9
1
|
919
|
|
|
‡a
randomizedcontrolledcomparisonofnephrostomydrainagevsureteralstentfollowingpercutaneousnephrolithotomyusingthewisconsinstoneqol
‡A
A Randomized Controlled Comparison of Nephrostomy Drainage vs Ureteral Stent Following Percutaneous Nephrolithotomy Using the Wisconsin StoneQOL.
‡9
1
|
919
|
|
|
‡a
advancedtherapyforprostatitisminimallyinvasiveandinvasivetherapies
‡A
Advanced therapy for prostatitis: minimally invasive and invasive therapies
‡9
1
|
919
|
|
|
‡a
advancesinpercutaneousstonesurgery
‡A
Advances in percutaneous stone surgery.
‡9
1
|
919
|
|
|
‡a
anatomicalvariationbetweenthepronesupineandsupineobliquepositionsoncomputedtomographyimplicationsforpercutaneousnephrolithotomyaccess
‡A
Anatomical variation between the prone, supine, and supine oblique positions on computed tomography: implications for percutaneous nephrolithotomy access.
‡9
1
|
919
|
|
|
‡a
angularpercutaneousrenalaccessmultipletractsthroughasingleincisionforstaghorncalculoustreatmentinasinglesession
‡A
"Angular percutaneous renal access". Multiple tracts through a single incision for staghorn calculous treatment in a single session
‡9
1
|
919
|
|
|
‡a
associationofestimatedglomerularfiltrationratewith24hurinalysisandstonecomposition
‡A
Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition
‡9
1
|
919
|
|
|
‡a
associationofserumbiochemicalmetabolicpanelwithstonecomposition
‡A
Association of serum biochemical metabolic panel with stone composition
‡9
1
|
919
|
|
|
‡a
bacilluscalmetteguerinforuppertracturothelialcanceristherearole
‡A
Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role?
‡9
1
|
919
|
|
|
‡a
bladdernecrosisassociatedwithplacentaaccretaembolizationandrepairofcystotomies
‡A
Bladder Necrosis Associated with Placenta Accreta, Embolization, and Repair of Cystotomies
‡9
1
|
919
|
|
|
‡a
calycealdiverticulaacomprehensivereview
‡A
Calyceal diverticula: a comprehensive review.
‡9
1
|
919
|
|
|
‡a
whichisbetterlivesurgicalbroadcastsvsaslivesurgicalbroadcasts
‡A
Which Is Better? "Live" Surgical Broadcasts vs "As-Live" Surgical Broadcasts
‡9
1
|
919
|
|
|
‡a
videourologyanhistoricalperspectiveandaviewtothefutureinterviewbyralph5clayman
‡A
Videourology: an historical perspective and a view to the future. Interview by Ralph V. Clayman
‡9
1
|
919
|
|
|
‡a
using24hoururinalysistopredictstonetype
‡A
Using 24-hour urinalysis to predict stone type
‡9
1
|
919
|
|
|
‡a
urinarytractinfectionsandpostoperativefeverinpercutaneousnephrolithotomy
‡A
Urinary tract infections and post-operative fever in percutaneous nephrolithotomy
‡9
1
|
919
|
|
|
‡a
ureteropelvicjunctionobstructionrepairwhenhowwhat
‡A
Ureteropelvic junction obstruction repair: when, how, what?
‡9
1
|
919
|
|
|
‡a
tubularcellescherichiacoliinteractionproductsmodulatemigrationofmonocytesthroughgenerationoftransforminggrowthfactorbetaandmacrophagemonocytechemoattractantprotein1
‡A
Tubular cell-Escherichia coli interaction products modulate migration of monocytes through generation of transforming growth factor-beta and macrophage-monocyte chemoattractant protein-1.
‡9
1
|
919
|
|
|
‡a
trendsinureteropelvicjunctionobstructionmanagementamongurologistsintheunitedstates
‡A
Trends in ureteropelvic junction obstruction management among urologists in the United States
‡9
1
|
919
|
|
|
‡a
surgicalspectacleasurveyofurologistsviewinglivecasedemonstrations
‡A
The surgical spectacle: a survey of urologists viewing live case demonstrations.
‡9
1
|
919
|
|
|
‡a
geneticframeworkfordevelopmentofnephrolithiasis
‡A
The genetic framework for development of nephrolithiasis.
‡9
1
|
919
|
|
|
‡a
expandeduseofpercutaneousresectionforuppertracturothelialcarcinomaa30yearcomprehensiveexperience
‡A
The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience
‡9
1
|
919
|
|
|
‡a
endourologicalmanagementofcomplicationsassociatedwithhorseshoekidney
‡A
The endourological management of complications associated with horseshoe kidney
‡9
1
|
919
|
|
|
‡a
debateoverpercutaneousnephrolithotomypositioningacomprehensivereview
‡A
The debate over percutaneous nephrolithotomy positioning: a comprehensive review
‡9
1
|
919
|
|
|
‡a
tandemureteralstentsforthedecompressionofmalignantandbenignobstructiveuropathy
‡A
Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy
‡9
1
|
919
|
|
|
‡a
tailstentversusreentrytubearandomizedcomparisonafterpercutaneousstoneextraction
‡A
Tail stent versus re-entry tube: a randomized comparison after percutaneous stone extraction.
‡9
1
|
919
|
|
|
‡a
symptomsafterremovalofureteralstents
‡A
Symptoms after removal of ureteral stents
‡9
1
|
919
|
|
|
‡a
stonesinspecialsituations
‡A
Stones in special situations
‡9
1
|
919
|
|
|
‡a
stentingformalignantureteralobstructiontandemmetalormetalmeshstents
‡A
Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents
‡9
1
|
919
|
|
|
‡a
stonenephrolithometrynovelsurgicalclassificationsystemforkidneycalculi
‡A
S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi.
‡9
1
|
919
|
|
|
‡a
roleofacellularcollagenmatrixsurgisisintheendoscopicmanagementofureteropelvicjunctionobstruction
‡A
Role of acellular collagen matrix surgisis in the endoscopic management of ureteropelvic junction obstruction.
‡9
1
|
919
|
|
|
‡a
rigidonlyversuscombinedrigidandflexiblepercutaneousnephrolithotomyasystematicreview
‡A
Rigid-only versus combined rigid and flexible percutaneous nephrolithotomy: a systematic review
‡9
1
|
919
|
|
|
‡a
residualairpersistsintherenalcollectingsystemfollowingpercutaneousnephrolithotomy
‡A
Residual Air Persists in the Renal Collecting System following Percutaneous Nephrolithotomy
‡9
1
|
919
|
|
|
‡a
replytopmid23540858
‡A
Reply: To PMID 23540858.
‡9
1
|
919
|
|
|
‡a
renalpelvicstoneschoosingshockwavelithotripsyorpercutaneousnephrolithotomy
‡A
Renal pelvic stones: choosing shock wave lithotripsy or percutaneous nephrolithotomy
‡9
1
|
919
|
|
|
‡a
renalfunctionaloutcomesarenotadverselyaffectedbyselectiveangioembolizationfollowingpercutaneousnephrolithotomy
‡A
Renal functional outcomes are not adversely affected by selective angioembolization following percutaneous nephrolithotomy.
‡9
1
|
919
|
|
|
‡a
renaldrainageafterpercutaneousnephrolithotomy
‡A
Renal drainage after percutaneous nephrolithotomy
‡9
1
|
919
|
|
|
‡a
reconstructionofrabbiturethrawithsurgisissmallintestinalsubmucosa
‡A
Reconstruction of rabbit urethra with surgisis small intestinal submucosa
‡9
1
|
919
|
|
|
‡a
realtimequantitationofrenalischemiausingtargetedmicrobubblesinvivomeasurementofpselectinexpression
‡A
Real-time quantitation of renal ischemia using targeted microbubbles: in-vivo measurement of P-selectin expression
‡9
1
|
943
|
|
|
‡a
198x
‡A
1982
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BNC|981058514560806706
|
996
|
|
|
‡2
RERO|A008912144
|
996
|
|
|
‡2
KRNLK|KAC200607563
|
996
|
|
|
‡2
BIBSYS|90342883
|
996
|
|
|
‡2
NII|DA04231785
|
996
|
|
|
‡2
BNE|XX4669916
|
996
|
|
|
‡2
CAOONL|ncf10049627
|
996
|
|
|
‡2
NUKAT|n 98700773
|
996
|
|
|
‡2
LC|n 2018184589
|
996
|
|
|
‡2
ISNI|0000000080217445
|
996
|
|
|
‡2
NYNYRILM|6792
|
996
|
|
|
‡2
NTA|224282603
|
996
|
|
|
‡2
ISNI|0000000115072881
|
996
|
|
|
‡2
RERO|A013662837
|
996
|
|
|
‡2
DNB|117634212
|
996
|
|
|
‡2
LC|n 78053303
|
996
|
|
|
‡2
ISNI|0000000080198715
|
996
|
|
|
‡2
CAOONL|ncf10057552
|
996
|
|
|
‡2
LC|n 84140791
|
996
|
|
|
‡2
DNB|127075739
|
996
|
|
|
‡2
NTA|166615994
|
996
|
|
|
‡2
SUDOC|060102446
|
996
|
|
|
‡2
ISNI|0000000054299002
|
996
|
|
|
‡2
RERO|A026614830
|
996
|
|
|
‡2
RERO|A009033743
|
996
|
|
|
‡2
DNB|115772596
|
996
|
|
|
‡2
SUDOC|181700174
|
996
|
|
|
‡2
LC|no2008129964
|
996
|
|
|
‡2
NLA|000035721616
|
996
|
|
|
‡2
LC|nb2001084041
|
996
|
|
|
‡2
SUDOC|075752573
|
996
|
|
|
‡2
DNB|1055220143
|
996
|
|
|
‡2
PLWABN|9810650771805606
|
996
|
|
|
‡2
NLA|000035505322
|
996
|
|
|
‡2
LC|no2012010459
|
996
|
|
|
‡2
NII|DA02641538
|
996
|
|
|
‡2
ISNI|0000000051341033
|
996
|
|
|
‡2
SUDOC|091984076
|
996
|
|
|
‡2
LC|nb2018013470
|
996
|
|
|
‡2
ISNI|0000000117572740
|
996
|
|
|
‡2
J9U|987007293049005171
|
996
|
|
|
‡2
ISNI|0000000416633582
|
996
|
|
|
‡2
ISNI|0000000037984921
|
996
|
|
|
‡2
J9U|987012851386605171
|
996
|
|
|
‡2
DNB|1157558860
|
996
|
|
|
‡2
NLA|000035505337
|
996
|
|
|
‡2
NUKAT|n 2012168136
|
996
|
|
|
‡2
LC|nr 91045503
|
996
|
|
|
‡2
BIBSYS|90194874
|
996
|
|
|
‡2
DNB|1229472614
|
996
|
|
|
‡2
NDL|001152328
|
996
|
|
|
‡2
SIMACOB|148232035
|
996
|
|
|
‡2
SUDOC|074456350
|
996
|
|
|
‡2
J9U|987007376057605171
|
996
|
|
|
‡2
SUDOC|028118723
|
996
|
|
|
‡2
NLA|000035541512
|
996
|
|
|
‡2
ISNI|0000000458754024
|
996
|
|
|
‡2
ISNI|0000000115762284
|
996
|
|
|
‡2
LC|n 96088468
|
996
|
|
|
‡2
LC|n 2011058417
|
996
|
|
|
‡2
SUDOC|103914676
|
996
|
|
|
‡2
BIBSYS|90150542
|
996
|
|
|
‡2
DNB|1158135831
|
996
|
|
|
‡2
ISNI|0000000079822963
|
996
|
|
|
‡2
NTA|416847552
|
996
|
|
|
‡2
SUDOC|191216895
|
996
|
|
|
‡2
LC|no 99055122
|
996
|
|
|
‡2
NUKAT|n 2007149814
|
996
|
|
|
‡2
NKC|jn19990008036
|
996
|
|
|
‡2
N6I|vtls001281323
|
996
|
|
|
‡2
DNB|1159306656
|
996
|
|
|
‡2
LC|no 89016226
|
996
|
|
|
‡2
ISNI|0000000047024991
|
996
|
|
|
‡2
NSK|000328349
|
996
|
|
|
‡2
RERO|A011405665
|
996
|
|
|
‡2
NTA|100034993
|
996
|
|
|
‡2
LC|n 2013042338
|
996
|
|
|
‡2
ISNI|0000000065608974
|
996
|
|
|
‡2
NDL|00757984
|
996
|
|
|
‡2
ISNI|0000000067261572
|
996
|
|
|
‡2
LC|n 81140801
|
996
|
|
|
‡2
PTBNP|1173433
|
996
|
|
|
‡2
NKC|xx0035811
|
996
|
|
|
‡2
ISNI|0000000038381962
|
996
|
|
|
‡2
NUKAT|n 2006044167
|
996
|
|
|
‡2
ISNI|0000000117533004
|
996
|
|
|
‡2
NUKAT|n 2006075020
|
996
|
|
|
‡2
VLACC|000030201
|
996
|
|
|
‡2
RERO|A003838825
|
996
|
|
|
‡2
NII|DA09145374
|
996
|
|
|
‡2
BNCHL|10000000000000000144577
|
996
|
|
|
‡2
NTA|069615047
|
996
|
|
|
‡2
ISNI|0000000117333635
|
996
|
|
|
‡2
J9U|987008729626905171
|
996
|
|
|
‡2
RERO|A003838742
|
996
|
|
|
‡2
PLWABN|9810636323505606
|
996
|
|
|
‡2
LC|n 2007042684
|
996
|
|
|
‡2
BIBSYS|6075271
|
996
|
|
|
‡2
PTBNP|1776184
|
996
|
|
|
‡2
BIBSYS|1022480
|
996
|
|
|
‡2
NSK|000185902
|
996
|
|
|
‡2
J9U|987011289363805171
|
996
|
|
|
‡2
LC|n 2002136654
|
996
|
|
|
‡2
ISNI|0000000080604488
|
996
|
|
|
‡2
ISNI|000000008383430X
|
996
|
|
|
‡2
BNF|13899864
|
996
|
|
|
‡2
NTA|241465974
|
996
|
|
|
‡2
LC|n 88635689
|
996
|
|
|
‡2
NUKAT|n 2008044657
|
996
|
|
|
‡2
BNF|12864605
|
996
|
|
|
‡2
DNB|173396739
|
996
|
|
|
‡2
BNF|17007292
|
996
|
|
|
‡2
ISNI|0000000049527947
|
996
|
|
|
‡2
NII|DA03686699
|
996
|
|
|
‡2
LC|nr 89017747
|
996
|
|
|
‡2
CAOONL|ncf11452260
|
996
|
|
|
‡2
NKC|jo2017941184
|
996
|
|
|
‡2
LC|no 00053278
|
996
|
|
|
‡2
NTA|070116180
|
996
|
|
|
‡2
ISNI|0000000083842895
|
996
|
|
|
‡2
ISNI|0000000047445518
|
996
|
|
|
‡2
ISNI|000000039845116X
|
996
|
|
|
‡2
LC|n 86804807
|
996
|
|
|
‡2
J9U|987007430895705171
|
996
|
|
|
‡2
ISNI|0000000073318133
|
996
|
|
|
‡2
ISNI|0000000109136738
|
996
|
|
|
‡2
B2Q|0000111131
|
996
|
|
|
‡2
ISNI|0000000043356710
|
996
|
|
|
‡2
J9U|987007279365905171
|
996
|
|
|
‡2
NTA|067481981
|
996
|
|
|
‡2
NII|DA04321108
|
996
|
|
|
‡2
BNF|14465806
|
996
|
|
|
‡2
LIH|LNB:CIY_q_;=B_s_
|
996
|
|
|
‡2
NTA|068844026
|
996
|
|
|
‡2
LNB|LNC10-000221981
|
996
|
|
|
‡2
RERO|A000150905
|
996
|
|
|
‡2
CAOONL|ncf10030511
|
996
|
|
|
‡2
RERO|A003838741
|
996
|
|
|
‡2
NUKAT|n 2009076682
|
996
|
|
|
‡2
DNB|1111012911
|
996
|
|
|
‡2
NII|DA09116820
|
996
|
|
|
‡2
DNB|1219979996
|
996
|
|
|
‡2
LC|no2018107013
|
996
|
|
|
‡2
ISNI|0000000028516253
|
996
|
|
|
‡2
LC|n 94116630
|
996
|
|
|
‡2
ISNI|0000000380405317
|
996
|
|
|
‡2
NLA|000035852932
|
996
|
|
|
‡2
LC|n 82115693
|
996
|
|
|
‡2
LC|n 2007042705
|
996
|
|
|
‡2
ISNI|0000000395263403
|
996
|
|
|
‡2
J9U|987007303990505171
|
996
|
|
|
‡2
SUDOC|085852651
|
996
|
|
|
‡2
LC|n 2002021987
|
996
|
|
|
‡2
SUDOC|105695823
|
996
|
|
|
‡2
BIBSYS|90901447
|
996
|
|
|
‡2
NII|DA02061243
|
996
|
|
|
‡2
LC|n 80060504
|
996
|
|
|
‡2
LC|no2013129958
|
996
|
|
|
‡2
LC|no2024128063
|
996
|
|
|
‡2
LC|nr 95008720
|
996
|
|
|
‡2
LC|no2008129956
|
996
|
|
|
‡2
LC|no2016147978
|
996
|
|
|
‡2
NYNYRILM|179593
|
996
|
|
|
‡2
SUDOC|080210309
|
996
|
|
|
‡2
B2Q|0000346577
|
996
|
|
|
‡2
DNB|132846802
|
996
|
|
|
‡2
B2Q|0000083523
|
996
|
|
|
‡2
LC|no2015011906
|
996
|
|
|
‡2
PLWABN|9810584580005606
|
996
|
|
|
‡2
LC|no2023103764
|
996
|
|
|
‡2
ISNI|0000000067629285
|
996
|
|
|
‡2
LC|n 78005527
|
996
|
|
|
‡2
LC|n 78094401
|
996
|
|
|
‡2
LC|n 94077223
|
996
|
|
|
‡2
NTA|158566599
|
996
|
|
|
‡2
NII|DA1677992X
|
996
|
|
|
‡2
SELIBR|342021
|
996
|
|
|
‡2
J9U|987007447910805171
|
996
|
|
|
‡2
ISNI|0000000036981921
|
996
|
|
|
‡2
LC|n 85800554
|
996
|
|
|
‡2
LC|nr 98039782
|
996
|
|
|
‡2
ISNI|0000000039160731
|
996
|
|
|
‡2
ISNI|0000000050856801
|
996
|
|
|
‡2
ISNI|000000004678944X
|
996
|
|
|
‡2
NII|DA04647706
|
996
|
|
|
‡2
LC|no2007159276
|
996
|
|
|
‡2
NUKAT|n 2018091342
|
996
|
|
|
‡2
LC|nb2011030518
|
996
|
|
|
‡2
ISNI|0000000080084654
|
996
|
|
|
‡2
BIBSYS|90326386
|
996
|
|
|
‡2
RERO|A027078980
|
996
|
|
|
‡2
LC|n 2021048707
|
996
|
|
|
‡2
PLWABN|9812830550105606
|
996
|
|
|
‡2
RERO|A011565825
|
996
|
|
|
‡2
ISNI|0000000397504098
|
996
|
|
|
‡2
BIBSYS|1682591864712
|
996
|
|
|
‡2
RERO|A027740340
|
996
|
|
|
‡2
RERO|A023879668
|
996
|
|
|
‡2
BIBSYS|90784601
|
996
|
|
|
‡2
BNF|12001696
|
996
|
|
|
‡2
LC|n 50016439
|
996
|
|
|
‡2
LC|n 50016438
|
996
|
|
|
‡2
BNF|11569575
|
996
|
|
|
‡2
SUDOC|25556080X
|
996
|
|
|
‡2
LC|no2022051933
|
996
|
|
|
‡2
NII|DA00692662
|
996
|
|
|
‡2
CAOONL|ncf12094078
|
996
|
|
|
‡2
CAOONL|ncf10022588
|
996
|
|
|
‡2
J9U|987007336536005171
|
996
|
|
|
‡2
PLWABN|9811717927305606
|
996
|
|
|
‡2
LC|no2023138934
|
996
|
|
|
‡2
NYNYRILM|31799
|
996
|
|
|
‡2
NTA|369574273
|
996
|
|
|
‡2
NTA|156859467
|
996
|
|
|
‡2
BNCHL|10000000000000000072187
|
996
|
|
|
‡2
NUKAT|n 2011213438
|
996
|
|
|
‡2
DNB|1124108157
|
996
|
|
|
‡2
BIBSYS|90267662
|
996
|
|
|
‡2
ISNI|0000000063036677
|
996
|
|
|
‡2
LC|no 89019719
|
996
|
|
|
‡2
SUDOC|077838602
|
996
|
|
|
‡2
J9U|987007354134005171
|
996
|
|
|
‡2
NKC|mub2016917607
|
996
|
|
|
‡2
LC|n 89603248
|
996
|
|
|
‡2
ISNI|0000000113720646
|
996
|
|
|
‡2
DNB|129292214
|
996
|
|
|
‡2
LC|n 88645499
|
996
|
|
|
‡2
SUDOC|15850934X
|
996
|
|
|
‡2
CAOONL|ncf10619652
|
996
|
|
|
‡2
LC|no2017027587
|
996
|
|
|
‡2
ISNI|0000000083865456
|
996
|
|
|
‡2
ISNI|0000000083932014
|
996
|
|
|
‡2
RERO|A022681820
|
996
|
|
|
‡2
N6I|vtls001104911
|
996
|
|
|
‡2
NTA|250286394
|
996
|
|
|
‡2
NUKAT|n 2016049296
|
996
|
|
|
‡2
ISNI|0000000040996886
|
996
|
|
|
‡2
NII|DA13910959
|
996
|
|
|
‡2
LC|n 79100467
|
996
|
|
|
‡2
DNB|119292629
|
996
|
|
|
‡2
DNB|1239672152
|
996
|
|
|
‡2
LC|nb2009031585
|
996
|
|
|
‡2
SUDOC|12018379X
|
996
|
|
|
‡2
LC|n 2007042795
|
996
|
|
|
‡2
NTA|192651242
|
996
|
|
|
‡2
RERO|A003838736
|
996
|
|
|
‡2
NII|DA02599034
|
996
|
|
|
‡2
LC|nb2017007795
|
996
|
|
|
‡2
RERO|A003838739
|
996
|
|
|
‡2
RERO|A003838738
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|